Capital is migrating from tools that optimize cost to systems that deliver agile, predictive performance.

S&OP once served as a monthly meeting focused on aligning sales forecasts with production plans. Today, it is expected to serve as the central nervous system for the entire business.

Most biopharma manufacturing and shipping is outsourced to CMOs and 3PLs, leaving a biotech firm with limited visibility into its shipment lifecycle.

Importers and logistics-intensive businesses without a bullet-proof trade and Customs compliance strategy, and strong due diligence process, have serious cause for concern.

AI capability will move from niche expertise to baseline literacy, on par with digital and data fluency. 

Gustav Khambatta, head of freight payment sales with U.S. Bank, introduces us to U.S. Bank Freight Payment.

A decision by the U.S. Supreme Court to strike down President Trump’s “emergency” tariffs won’t be the last word on the tariff controversy.

Greg Husisian, trade attorney with Foley & Lardner, reviews the statutory options that President Trump can invoke to justify his imposition of tariffs on U.S. trading partners.

Preparing for further tariff-driven shocks, as well as accelerating investment in technology and automation, are critical for business sustainability.

M&A activity is not roaring back, but it is clearly on the uptick, with buyers allocating capital to acquisitions in a discerning yet deliberate way.